First American Trust FSB Trims Stake in Boston Scientific Corporation (BSX)

Marco Green
January 20, 2018

Thus, it is essential to run your own analysis on Boston Scientific's future earnings whilst maintaining a watchful eye over the sustainability of their cost management methods and the runway for top line growth.

Boston Scientific Corporation (NYSE:BSX) gained 1 Percent and closed its previous trading session at $27.25. About 3.39 million shares traded.

In other news, SVP David A. Pierce sold 10,232 shares of Boston Scientific Corporation stock in a transaction on Monday, January 9th. It has outperformed by 2.42% the S&P500. Winslow Capital Management LLC now owns 11,212,783 shares of the medical equipment provider's stock worth $310,818,000 after purchasing an additional 2,011,640 shares during the period. During the same quarter in the previous year, the company posted $0.27 earnings per share. It is now trading 2.68% off that level. It has outperformed by 1.08% the S&P500.

Institutions own 94.19% of Boston Scientific Corporation (BSX)'s shares. Therefore 79% are positive. PRIMECAP MANAGEMENT CO/CA/ also announced decreased position in Boston Scientific Corporation (BSX) during the quarter. The insider now holds 71,448 shares of Boston Scientific Corporation (BSX).

A number of research firms have recently commented on BSX. Thompson Siegel And Walmsley Ltd invested 0% in Boston Scientific Corporation (NYSE:BSX). BMO Capital Markets reaffirmed a "buy" rating and set a $30.00 price objective on shares of Boston Scientific in a research report on Friday, October 13th. BMO Capital Markets has "Buy" rating and $31.0 target.

Gateway Investment Advisers LLC reduced its position in Boston Scientific Corporation (NYSE:BSX) by 16.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). Societe Generale upgraded British American Tobacco p.l.c. (NYSE:BTI) on Friday, October 28 to "Buy" rating. The firm has "Buy" rating given on Monday, September 28 by Needham. Those invested in the stock should contemplate the factors that are causing this projected increase, because the sustainability of returns to shareholders can be impacted on in different ways. Its up 0.01, from 1.03 in 2017Q2. $10.11M worth of Boston Scientific Corporation (NYSE:BSX) was sold by Bose Supratim.

VANGUARD GROUP INC raised its stake in Gilead Sciences, Inc.

For the ongoing Fiscal Quarter, 18 analysts have an average earnings forecast of $1.19 per share. Deutsche National Bank Ag, Germany-based fund reported 782,071 shares. Shares are clocking price at $27.25 with change of 1.00%. Moreover, Ww Asset Mngmt has 0.13% invested in Boston Scientific Corporation (NYSE:BSX). Boston Scientific Corporation (NYSE:BSX) has risen 19.12% since January 17, 2017 and is uptrending. High Pointe Limited Liability holds 0.83% or 19,430 shares in its portfolio. Old Mutual Customised Solutions (Proprietary) reported 0.07% stake. The Connecticut-based Virtus Advisers has invested 0.09% in Boston Scientific Corporation (NYSE:BSX). Boston Prns invested in 7.20 million shares. 34,311 are owned by Ibm Retirement Fund. Ontario Teachers Pension Plan Board holds 272,371 shares or 0.11% of its portfolio.

Athena Capital Advisors Llc, which manages about $5.10B and $388.33 million US Long portfolio, decreased its stake in Powershs Db Multi Sect Comm (DBA) by 44,527 shares to 122,921 shares, valued at $2.33M in 2017Q3, according to the filing.

Since August 1, 2017, it had 0 insider buys, and 13 insider sales for $15.16 million activity. Phalen Michael P. sold 15,835 shares worth $399,865. Greenwood Capital Associates LLC now owns 91,579 shares of the medical equipment provider's stock worth $2,671,000 after purchasing an additional 38,249 shares during the last quarter. $1.56 million worth of Boston Scientific Corporation (NYSE:BSX) was sold by Nanavaty Maulik. $208,328 worth of Boston Scientific Corporation (NYSE:BSX) was sold by Sorenson John Bradley on Wednesday, August 2. Another trade for 12,433 shares valued at $332,584 was made by Carruthers Wendy on Thursday, August 3.

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. Iguana Healthcare Management Llc who had been investing in Boston Scientific Corp for a number of months, seems to be bullish on the $37.71 billion market cap company. Therefore, P/E ratio should be used cautiously.

Caisse De Depot Et Placement Du Quebec increased Wells Fargo & Co (NYSE:WFC) stake by 443,000 shares to 3.59M valued at $198.89M in 2017Q3. Imax Corp (Call) (NYSE:IMAX) was raised too.

Analysts await Philip Morris International Inc. They expect $1.36 EPS, up 23.64% or $0.26 from last year's $1.1 per share. The shares price showing change of 10.77% so far this year and performed with flow of 16.75% during recent year.

Investors sentiment decreased to 1.32 in Q3 2017. It improved, as 33 investors sold BSX shares while 166 reduced holdings. Nomura Incorporated accumulated 69,811 shares. Given the stock's recent action, it seemed like a good time to take a closer look at the company's recent data. Wealthfront accumulated 27,956 shares. The company's outstanding shares are 1.37 Billion. Main Street Rech Ltd Liability Company stated it has 0.84% in McDonald's Corporation (NYSE:MCD). It has met expectations 0 times and missed earnings 2 times. Benjamin F Edwards holds 304 shares or 0% of its portfolio. Greenwood Capital Assoc Limited Liability reported 91,579 shares.

Other reports by Click Lancashire

Discuss This Article